.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
In the first arrangement of its kind, Eli Lilly to connect patients through tele...
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept...
Fields and business rules for the European Shortages Monitoring Platform (ESMP) ...
European shortages monitoring platform (ESMP) API - Instructions to request acce...
European shortages monitoring platform (ESMP) API - Request access to ESMP API f...
European Shortages Monitoring Platform (ESMP) open Application Programming Inter...
Guidance for Rapporteurs and members of drafting groups of documents developed b...
Three year work plan for the Good Manufacturing Practice / Good Distribution Pra...
Annual report of the Good Manufacturing and Distribution Practice Inspectors Wor...
Good Manufacturing Practice (GMP) / Distribution Practice Practice (GDP) Inspect...
PIPEs were once the buzziest financing vehicle in biotech. Here's a look at how ...
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib...
Human medicines European public assessment report (EPAR): Strimvelis, autologous...
Human medicines European public assessment report (EPAR): Eurneffy, epinephrine,...
Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib...
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, D...
Imagine standing on a vast, dark plain. Without light, you cannot see dips and r...
If SAMHSA’s footprint shrinks, will the agency and the country be prepared to re...
Block-granting Medicaid won’t be easy. But the payoff would be well worth the ef...
New in STAT's Breakthrough Devices Tracker: An AI-powered disease detection chat...
REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, In...
On Jay Bhattacharya's first day as NIH director, the agency directed staff to id...
The largest U.S. pension fund Wednesday cited STAT reporting in an amended lawsu...
The FDA Wednesday approved the first drug to treat people with Prader-Willi synd...